Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

AGM Statement

23 Jul 2025 07:00

RNS Number : 1129S
Symphony Environmental Tech. PLC
23 July 2025
 

 

23 July 2025

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

("Symphony", the "Company" or the "Group")

AGM Statement

 

Symphony Environmental Technologies Plc (AIM:SYM) global specialists in technologies that make plastic and rubber products "smarter, safer and sustainable" announces that its Chairman will make the following statement at today's Annual General Meeting.

"I am very pleased to report that momentum within the business continues, and our prospects look strong, especially in the short to medium term. We are seeing a high level of sales prospects nearing completion and expected to close in the second half of the year or shortly after.

A major highlight this year has been the long-awaited regulatory breakthrough in the EU. As announced on 8 July 2025, the Environmental Protection Agency ("EPA") of Ireland (an EU Member-State) confirmed that Symphony's d2w biodegradable plastic technology is compliant with EU Directive (EU) 2019/904 (the "Directive"). Other European markets can be expected to follow.

This confirmation of compliance is the result of a thorough scientific review by the EPA of Ireland of a large file of independent scientific reports which confirm that products with d2w technology fully biodegrade without leaving persistent microplastics or toxic residues: a critical distinction from oxo-degradable plastics - which are restricted under the Directive.

The EPA of Ireland has also reviewed the Commission Notice (2021/C 216/01) of 7 June 2021, which provides guidelines on the implementation of Directive (EU) 2019/904. They said, "Based on the evidence submitted, we are satisfied that d2w products are not subject to the restrictions outlined in the Directive or its accompanying guidelines."

It is important to note that the scientific evidence submitted to the EPA related to d2w only, and their approval therefore relates only to d2w and to no other biodegradable plastic.

This development is not only an official validation of our technology but also a strategic enabler for growth of d2w across Europe and in other global markets which align with the EU's environmental strategies.

Indeed, it marks a significant turning point in our commercial trajectory and strengthens our leadership in the market for sustainable plastic solutions that have little or no on-cost and are non-disruptive to supply-chains.

Our d2p range of products, as reported in our preliminary results on 12 June continues to progress in the following main areas. Antimicrobial for bread and other food applications, flame retardants, fragrance scents for use in refrigerators, and anti-insect applications for water pipe and some food packing protection. 

Our balance sheet was strengthened by the equity capital-raise announced on 10 June of £2.25 million at 20 pence per share.

Revenues for the first half of 2025 were approximately £2.9 million (H1 2024: £3.4 million). While Q2 2025 was particularly light, this was due to order timing in key markets and is not indicative of underlying trading conditions. We expect a stronger performance in the second half as expected orders are received, and our opportunities commercialise further.

Our gross margins have continued to strengthen and are expected to be approximately 5 percentage points higher than H1-2024. Costs have continued to reduce.

Symphony remains well positioned globally, operating a capital-light, operationally- geared business model. We continue to work closely with a global network of experienced distributors and manufacturing partners in key territories."

 

Enquiries:

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Zeus (Nominated Adviser and Broker)

David Foreman, Emma Burn (Investment Banking)

Tel: +44 (0) 203 829 5000

Dominic King (Sales)

Tel: +44 (0) 203 829 5000

NOTES TO EDITORS

 

About Symphony Environmental

 

 

Symphony's d2w masterbatch technology is added to polyethylene (PE) and polypropylene (PP) products at the manufacturing stage at little or no extra cost, and ensures that if they get into the environment at the end of their useful life they will not create microplastics and lie or float around for decades. Instead they will safely biodegrade, leaving no microplastics or toxicity. If they get collected during their useful life they can be recycled with ordinary PE and PP without separation See https://www.biodeg.org/subjects-of-interest/recycling-2/

 

Symphony also supplies a range of plastic technologies under its d2p (designed to protect) brand www.d2p.net to provide protection against insects, viruses, bacteria, fungi, rodents, odours, and fire. It has also introduced a new product under its NbR brand https://www.symphonyenvironmental.com/natural-biodegradable-resin/ to reduce the amount of fossil-derived material in plastic products.

 

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is certified according to ISO9001 and ISO14001.

 

Symphony actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv

 

See also Symphony on Instagram and Linkedin.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEAFLEEISEIW
Date   Source Headline
19th Nov 20218:24 amRNSExpansion into India
12th Nov 20213:04 pmRNSSmall Cap Awards: ESG Company of the Year
25th Oct 20217:00 amRNSExclusive Distribution Agreement
5th Oct 20219:58 amRNSHolding(s) in Company
24th Sep 20217:00 amRNSEquity subscription and grant of warrants
16th Sep 20217:00 amRNSInterim results
3rd Sep 20217:00 amRNSHealth Canada approves d2p for bread packaging
2nd Aug 20217:30 amRNSNew agreements with Meditech
27th Jul 20213:00 pmRNSHolding(s) in Company
14th Jul 20217:00 amRNSNew expanded FDA approval for d2p food packaging
13th Jul 20217:00 amRNSTrading update
28th Jun 202111:56 amRNSResult of AGM
11th Jun 202110:04 amRNSHolding(s) in Company
9th Jun 20217:00 amRNSPDMR Dealing
3rd Jun 20217:00 amRNSPosting of accounts & notice of AGM
13th May 20217:00 amRNSEU legal challenge update
23rd Apr 20217:32 amRNSd2p anti-microbial technology to protect commuters
13th Apr 20212:40 pmRNSDirector Dealing
1st Apr 20213:23 pmRNSDirector Dealing
31st Mar 20217:00 amRNSPreliminary results
30th Mar 20217:00 amRNSCompletion of 5 year Oxomar study re. d2w
12th Mar 20217:00 amRNSEU legal challenge update
9th Feb 20217:00 amRNSTrading update
21st Dec 20207:00 amRNSEU legal action
30th Nov 20207:00 amRNSPositive Coronavirus Test Results of d2p products
16th Nov 20207:00 amRNSNew d2p product launch
9th Nov 20204:40 pmRNSSecond Price Monitoring Extn
9th Nov 20204:36 pmRNSPrice Monitoring Extension
30th Oct 20207:00 amRNSLaunch of d2p and d2w enhanced drinking straws
20th Oct 20207:00 amRNSCompletion of Eranova project financing
19th Oct 20207:00 amRNSLargest Bakery in Turkey Launches d2w Packaging
9th Oct 20207:00 amRNSExtension of Options
5th Oct 20205:52 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSUK Airport Group introduces d2w biodegradable bag
22nd Sep 20207:00 amRNSCotripal launches d2p and d2w shopping bags
16th Sep 20207:00 amRNSInvestor Meet Company presentation
15th Sep 20207:00 amRNSExercise of warrants
14th Sep 20204:40 pmRNSSecond Price Monitoring Extn
14th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:01 amRNSPositive Coronavirus test results
14th Sep 20207:00 amRNSInterim results
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:35 pmRNSPrice Monitoring Extension
12th Aug 20204:40 pmRNSSecond Price Monitoring Extn
12th Aug 20204:36 pmRNSPrice Monitoring Extension
4th Aug 20204:09 pmRNSPDMR dealing
29th Jul 20207:00 amRNSExercise of Options/PDMR dealing
28th Jul 20207:00 amRNSExercise of Options
23rd Jul 20207:00 amRNSPositive Bovine Coronavirus Test Results
22nd Jul 20207:00 amRNSExtension of warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.